Karine Fiore

发表

14 No-fault compensation systems

Karine Fiore, 2014 .

Concerns related to ED-mediated effects of Bisphenol A and their regulatory consideration

C. Rousselle, C. Beausoleil, Karine Fiore, 2018, Molecular and Cellular Endocrinology.

Burden of osteoporosis and costs associated with human biomonitored cadmium exposure in three European countries: France, Spain and Belgium.

C. Rousselle, E. Ougier, J. Buekers, 2021, International journal of hygiene and environmental health.

The Government as Reinsurer of Catastrophe Risks?

M. Faure, Karine Fiore, Véronique Bruggeman, 2010 .

The Nuclear Liability Limit in the OECD Conventions: An Implicit Subsidy

Karine Fiore, 2008 .

Nuclear energy and sustainability : Understanding ITER

Karine Fiore, 2006 .

Irreversibilities and technological change: modularity as a new challenge for nuclear investments?

Karine Fiore, 2007 .

The Coverage of the Nuclear Risk in Europe: Which Alternative?

M. Faure, Karine Fiore, 2008 .

Socio-economic analysis in the framework of REACH Regulation: a case study of the restriction of Bisphenol A in thermal paper

Karine Fiore, 2018 .

An Economic Analysis of the Nuclear Liability Subsidy

M. Faure, Karine Fiore, 2009, Pace Environmental Law Review.

Euratom and the EU Enlargement: What New Regulatory Framework for a Sustainable Nuclear Common Market?

Karine Fiore, 2007 .

The civil liability of European nuclear operators: which coverage for the new 2004 Protocols? Evidence from France

M. Faure, Karine Fiore, 2008 .

An Economic Analysis of the French Nuclear Liability Subsidy

M. Faure, Karine Fiore, 2005 .